Big Gain For Bellerophon Therapeutics, Inc.
Wed, Jun 23, 2021 at 05:30 PM
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) rocketted at $5.32, a gain of 30.4%. On Tue, Jun 22, 2021, BLPH:NASDAQ touched a New 2-Week Intraday Low of $3.94. The stock appeared on our News Catalysts scanner on Wed, Jun 09, 2021 at 01:22 PM in the 'BIOTECH' category. From Tue, Jun 08, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- MCAE (MCAE:NASDAQ), 100%
- Entera Bio Ltd. (ENTX:NASDAQ), 44.77%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 30.39%
- ORPH (ORPH:NASDAQ), 24.62%
- Moxian, Inc. (MOXC:NASDAQ), 21.98%
- Loop Industries, Inc. (LOOP:NASDAQ), 20.55%
- KRBP (KRBP:NASDAQ), 20.54%
- AUUD (AUUD:NASDAQ), 18.54%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 18.5%
- SeaChange International, Inc. (SEAC:NASDAQ), 18.1%